参考文献/References:
[1] Younossi ZM,Koenig AB,Abdelatif D,et al. Global epidemiology of nonalcoholic fatty liver disease--meta-analytic assessment of prevalence, incidence, and outcomes[J].Hepatology,2016,64(1):73-84.DOI:10.1002/hep.28431.
[2] Bellentani S,Saccoccio G,Masutti F,et al.Prevalence of and risk factors for hepatic steatosis in Northern Italy[J].Ann Intern Med,2000,132(2):112-117. DOI:10.7326/0003-4819-132-2-200001180-00004.
[3] Luyckx FH,Desaive C,Thiry A,et al.Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty[J].Int J Obes Relat Metab Disord,1998,22(3):222-226.
[4] GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015[J].Lancet,2016,388(10053):1545-1602.DOI:10.1016/S0140-6736(16)31678-6.
[5] Tfayli H,Arslanian S.Pathophysiology of type 2 diabetes mellitus in youth: the evolving chameleon[J].Arq Bras Endocrinol Metabol,2009,53(2):165-174.
[6] Imperatore G,Boyle JP,Thompson TJ,et al.Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth[J].Diabetes Care,2012,35(12):2515-2520.DOI:10.2337/dc12-0669.
[7] Hara H,Uchida S,Yoshimura H,et al.Isolation and characterization of a novel liver-specific gene, hepassocin, upregulated during liver regeneration[J].Biochim Biophys Acta,2000,1492(1):31-44.DOI:10.1016/s0167-4781(00)00056-7.
[8] Hara H,Yoshimura H,Uchida S,et al.Molecular cloning and functional expression analysis of a cDNA for human hepassocin, a liver-specific protein with hepatocyte mitogenic activity[J].Biochim Biophys Acta,2001,1520(1):45-53.DOI:10.1016/s0167-4781(01)00249-4.
[9] Yan J,Yu Y,Wang N,et al.LFIRE-1/HFREP-1,a liver-specific gene, is frequently downregulated and has growth suppressor activity in hepatocellular carcinoma[J].Oncogene,2004,23(10):1939-1949.DOI:10.1038/sj.onc.1207306.
[10] Ou HY,Wu HT,Lin CH,et al.The hepatic protection effects of hepassocin in hyperglycemic crisis[J].J Clin Endocrinol Metab,2017,102(7):2407-2415.DOI:10.1210/jc.2016-3287.
[11] Yu HT,Yu M,Li CY,et al.Specific expression and regulation of hepassocin in the liver and down-regulation of the correlation of HNF1alpha with decreased levels of hepassocin in human hepatocellular carcinoma[J].J Biol Chem,2009,284(20):13335-13347.DOI:10.1074/jbc.M806393200.
[12] Cheng KP,Ou HY,Hung HC,et al.Unsaturated fatty acids increase the expression of hepassocin through a signal transducer and activator of transcription 3-dependent pathway in HepG2 cells[J].Lipids,2018,53(9):863-869.DOI:10.1002/lipd.12099.
[13] Jung TW,Chung YH,Kim HC,et al.Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletalmuscle[J].Mol Cell Endocrinol,2018,470:26-33.DOI:10.1016/j.mce.2017.10.014.
[14] Wu HT,Lu FH,Ou HY,et al.The role of hepassocin in the development of non-alcoholic fatty liver disease[J].J Hepatol,2013,59(5):1065-1072.DOI:10.1016/j.jhep.2013.06.004.
[15] Gao M,Yan H,Yin RH,et al.Hepassocin is required for hepatic outgrowth during zebrafish hepatogenesis[J].Biochem Biophys Res Commun,2015,463(3):466-471.DOI:10.1016/j.bbrc.2015.05.121.
[16] Cao MM,Xu WX,Li CY,et al.Hepassocin regulates cell proliferation of the human hepatic cells L02 and hepatocarcinoma cells through different mechanisms[J].J Cell Biochem,2011,112(10):2882-2890.DOI:10.1002/jcb.23202.
[17] Li CY,Cao CZ,Xu WX,et al.Recombinant human hepassocin stimulates proliferation of hepatocytes in vivo and improves survival in rats with fulminant hepatic failure[J].Gut,2010,59(6):817-826.DOI:10.1136/gut.2008.171124.
[18] Gao M,Zhan YQ,Yu M,et al.Hepassocin activates the EGFR/ERK cascade and induces proliferation of L02 cells through the Src-dependent pathway[J].Cell Signal,2014,26(10):2161-2166.DOI:10.1016/j.cellsig.2014.04.013.
[19] Demchev V,Malana G,Vangala D,et al.Targeted deletion of fibrinogen like protein 1 reveals a novel role in energy substrate utilization[J].PLoS One,2013,8(3):e58084.DOI:10.1371/journal.pone.0058084.
[20] Nayeb-Hashemi H,Desai A,Demchev V,et al.Targeted disruption of fibrinogen like protein-1 accelerates hepatocellular carcinoma development[J].Biochem Biophys Res Commun,2015,465(2):167-173.DOI:10.1016/j.bbrc.2015.07.078.
[21] Zou Z,Cai Y,Chen Y,et al.Bone marrow-derived mesenchymal stem cells attenuate acute liver injury and regulate the expression of fibrinogen-like-protein 1 and signal transducer and activator of transcription 3[J].Mol Med Rep,2015,12(2):2089-2097.DOI:10.3892/mmr.2015.3660.
[22] Rijken DC,Dirkx SP,Luider TM,et al.Hepatocyte-derived fibrinogen-related protein-1 is associated with the fibrin matrix of a plasmaclot[J].Biochem Biophys Res Commun,2006,350(1):191-194.DOI:10.1016/j.bbrc.2006.09.018.
[23] Liu Z, Ukomadu C.Fibrinogen-like protein 1, a hepatocyte derived protein is an acute phase reactant[J].Biochem Biophys Res Commun,2008,365(4):729-734.DOI:10.1016/j.bbrc.2007.11.069.
[24] Fu S,Fan J,Blanco J,et al.Polysome profiling in liver identifies dynamic regulation of endoplasmic reticulum translatome by obesity and fasting[J].PLoS Genet,2012,8(8):e1002902.DOI:10.1371/journal.pgen.1002902.
[25] Abdelmoemen G,Khodeir SA,Zaki AN,et al.Overexpression of hepassocin in diabetic patients with nonalcoholic fatty liver disease may facilitate increased hepatic lipid accumulation[J].Endocr Metab Immune Disord Drug Targets,2019,19(2):185-188.DOI:10.2174/1871530318666180716100543.
[26] Sreekumar R,Rosado B,Rasmussen D,et al.Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis[J].Hepatology,2003,38(1):244-251.DOI:10.1053/jhep.2003.50290.
[27] Wu HT,Ou HY,Hung HC,et al.A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes[J].Diabetologia,2016,59(8):1732-1742.DOI:10.1007/s00125-016-3991-7.